Recursion Pharmaceuticals, Inc. (RXRX)
3.10
-0.05
(-1.59%)
USD |
NASDAQ |
May 13, 10:26
Recursion Pharmaceuticals Free Cash Flow : -328.08M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -363.62M |
| Tango Therapeutics, Inc. | -139.93M |
| KalVista Pharmaceuticals, Inc. | -- |
| Ionis Pharmaceuticals, Inc. | -977.73M |
| Ironwood Pharmaceuticals, Inc. | 112.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -81.10M |
| Cash from Investing (Quarterly) | -0.338M |
| Cash from Financing (Quarterly) | -3.47M |
| Free Cash Flow Per Share (Quarterly) | -0.1539 |
| Free Cash Flow to Equity (Quarterly) | -75.85M |
| Free Cash Flow to Firm (Quarterly) | -81.10M |
| Free Cash Flow Yield | -22.04% |